Document:

<PAGE>
                                                                   EXHIBIT 10.3

            DYNAMEX INC. AMENDED AND RESTATED 1996 STOCK OPTION PLAN

                                    SECTION 1
                                     PURPOSE

         The purposes of this Dynamex Inc. Amended and Restated 1996 Stock
Option Plan (this "Plan") are to attract and retain the best available employees
and directors of Dynamex Inc. (the "Company") and any Parent or Subsidiary of
the Company (each as hereinafter defined), to provide additional incentive to
such persons and to promote the success of the business of the Company. This
Plan is intended to comply with Rule 16b-3 under Section 16 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or any successor
provision ("Rule 16b-3"), and this Plan shall be construed, interpreted and
administered to so comply. This Plan amends and restates the Dynamex Inc.1996
Stock Option Plan.

                                    SECTION 2
                                OTHER DEFINITIONS

         As used in this Plan:

         "Board" means the Board of Directors of the Company.

         "Code" means the Internal Revenue Code of 1986, as amended from time to
time.

         "Committee" means the Compensation Committee or other committee
appointed by the Board, which shall consist of two or more directors, each of
whom shall be a "disinterested person" within the meaning of Rule 16b-3(c) under
the Exchange Act, or any successor provision.

         "Common Stock" means the Common Stock, $.01 par value, of the Company.

         "Effective Date" means June 5, 1996.

         "ERISA" means the Employee Retirement Income Security Act of 1974, as
amended from time to time.

         "Fair Market Value" means, with respect to the Common Stock and at any
date, (i) the reported closing price of such stock on the New York Stock
Exchange or other established stock exchange or the Nasdaq National Market
System on such date, or if no sale of such stock shall have been made on such an
exchange or the Nasdaq National Market System on that date, on the preceding
date on which there was such a sale, (ii) if such stock is not then listed on
such an exchange or quoted on the Nasdaq National Market System, the average of
the closing bid and asked prices per share for such stock in the
over-the-counter market as quoted on the National Association of Securities
Dealers, Inc. Automated Quotation System ("Nasdaq") on such date, or (iii) if
such stock is not then listed on such an exchange or quoted on Nasdaq or the
Nasdaq

                                       1
<PAGE>

National Market System, an amount determined in good faith by the Committee in
its sole discretion.

         "Incentive Stock Option" means an option to purchase shares of Common
Stock awarded to a Participant under this Plan which is intended to meet the
requirements of Section 422 of the Code or any successor provision.

         "Non-Employee Director" means a director of the Company who is not an
employee of the Company or any parent or Subsidiary of the Company.

         "Non-Qualified Stock Option" means an option to purchase shares of
Common Stock awarded to a Participant under this Plan which is not intended to
be an Incentive Stock Option.

         "Option" means an Incentive Stock Option or a Non-Qualified Stock
Option.

         "Parent" means a "parent corporation," whether now or hereafter
existing, as defined in Section 424(e) of the Code.

         "Participant" means a person selected by the Committee to receive an
award under this Plan and Non-Employee Directors.

         "Restricted Stock" means Common Stock awarded to a Participant subject
to restrictions pursuant to the Plan.

         "Restricted Stock Grant" means an award of shares of Restricted Stock.

         "Section 16 Participant" means a Participant subject to Section 16 of
the Exchange Act.

         "Securities Act" means the Securities Act of 1933, as amended from time
to time.

         "Subsidiary" means a "subsidiary corporation," whether now or hereafter
existing, as defined in Section 424(f) of the Code.

                                    SECTION 3
                                 ADMINISTRATION

         (a) Committee Authority; Delegation. This Plan shall be administered by
the Committee. Among other things, the Committee shall have authority, subject
to the terms of this Plan (including, without limitation, the provisions
governing participation in this Plan by Non-Employee Directors), to grant awards
under this Plan and to determine the individuals to whom and the time or times
at which awards may be granted, the type(s) of award(s) to be granted to such
individuals pursuant to this Plan and the terms and conditions of such awards.
All administrative powers may be delegated by the Committee, except where (i)
such powers with respect to the selection of and determination of awards for
Section 16 Participants are required to be exercised by the Committee in order
to enable this Plan to qualify for the exemption provided

                                        2
<PAGE>

by Rule 16b-3 or (ii) such delegation would cause the benefits under this Plan
to "covered employees" within the meaning of Section 162(m) of the Code to not
qualify as performance-based compensation within the meaning of Section 162(m)
of the Code and applicable interpretive authority thereunder.

         (b) Actions of Committee. Subject to the provisions of Section 10(e)
hereof, the Committee shall have authority to adopt, alter and repeal such
administrative rules, guidelines and practices governing the operation of this
Plan as it shall from time to time consider advisable, to interpret the
provisions of this Plan and any Option Agreement or Restricted Stock Agreement
(each as hereinafter defined), and to decide all disputes arising in connection
with this Plan. The Committee's decisions and interpretations shall be final and
binding. Any action of the Committee with respect to the administration of this
Plan shall be taken pursuant to a majority vote or by the unanimous written
consent of its members.

         (c) Indemnification. The Company shall indemnify and hold harmless each
director of the Company and each Committee member for any action or
determination made in good faith with respect to this Plan or any Option
Agreement or Restricted Stock Agreement.

                                    SECTION 4
                                   ELIGIBILITY

         The following individuals shall be eligible to receive awards pursuant
to this Plan as follows:

         (a) Any employee (including any officer or director who is an employee)
of the Company or any Parent or Subsidiary of the Company shall be eligible to
receive Incentive Stock Options under this Plan. Any employee (including any
officer or director who is an employee) of the Company or any Parent, Subsidiary
or other affiliate of the Company shall be eligible to receive Non-Qualified
Stock Options and Restricted Stock Grants under this Plan. Eligible employees
may receive more than one Option or Restricted Stock Grant under this Plan.

         (b) Any Non-Employee Director of the Company shall be eligible to
receive Options and Restricted Stock Grants only as set forth in Section 8
hereof.

                                    SECTION 5
                         STOCK AVAILABLE UNDER THIS PLAN

         (a) Number of Shares Available. Subject to any adjustments made
pursuant to Section 5(b) hereof, the aggregate number of shares of Common Stock
that may be delivered pursuant to the exercise of all Options granted and
pursuant to all Restricted Stock Grants awarded under this Plan shall be
1,100,000, of which no more than 110,000 shares may be delivered pursuant to
Restricted Stock Grants and the exercise of Options awarded to Non-Employee
Directors in accordance with Section 8 hereof. If any Option expires or is
terminated before exercise or if any portion of any Restricted Stock Grant is
forfeited for any reason, the

                                       3
<PAGE>

shares of Common Stock which were subject to but were either forfeited to the
Company or not delivered under such Option or Restricted Stock Grant, and any
other shares of Common Stock that for any other reason are not issued to a
Participant, shall again be available for award under this Plan as if no Option
or Restricted Stock Grant had been awarded with respect to such shares. Awards
under this Plan may be fulfilled with either authorized and unissued shares of
Common Stock or issued and reacquired shares of Common Stock.

         (b) Adjustment. In the event of a stock dividend, stock split or
combination of shares of Common Stock, recapitalization or other increase or
decrease in the number of issued shares of Common Stock effected without receipt
of consideration by the Company, appropriate and proportionate adjustment shall
be made in (i) the number and kind of shares of stock in respect of which
Options or Restricted Stock Grants may be awarded under this Plan, (ii) the
number and kind of shares of stock or other property subject to outstanding
Options and Restricted Stock Grants, and (iii) the award, exercise or conversion
price with respect to any of the foregoing.

                                    SECTION 6
                         TERMS AND CONDITIONS OF OPTIONS

         (a) Grants of Options. Subject to the provisions of this Plan, the
Committee may award Incentive Stock Options and Non-Qualified Stock Options and
determine the number of shares to be covered by each Option, the option price
therefor, the term of the Option, and the other conditions and limitations
applicable to the exercise of the Option. The terms and conditions of Incentive
Stock Options shall be subject to and comply with Section 422 of the Code, or
any successor provision, and any regulations thereunder. Each grant of an Option
may be made alone or in combination with, in addition to or in relation to any
other award authorized by this Plan. The terms of each Option need not be
identical, and the Committee need not treat Participants uniformly. Except as
otherwise provided by this Plan or a particular Option Agreement, any
determination with respect to an Option may be made by the Committee at the time
of award or at any time thereafter.

         (b) Agreement in Writing; Provisions. Each Option under this Plan shall
be evidenced by a written agreement (each, an "Option Agreement") delivered to
the Participant specifying the terms and conditions thereof and containing such
other terms and conditions not inconsistent with the provisions of this Plan as
the Committee considers necessary or advisable to achieve the purposes of this
Plan or comply with applicable tax and regulatory laws and accounting
principles. Each Option Agreement shall specify whether the Options granted
thereby are Incentive Stock Options or Non-Qualified Stock Options.

         (c) Option Price. The option price per share of Common Stock
purchasable under an Option shall be 100% of the Fair Market Value of the Common
Stock on the date of award. If the Participant owns or is deemed to own (by
reason of the attribution rules applicable under Section 424(d) of the Code)
more than 10% of the combined voting power of all classes of stock of the
Company or any Subsidiary or Parent of the Company and an Incentive Stock Option
is granted to such Participant, the option price shall be 110% of Fair Market
Value of the Common Stock on the date of award.

                                       4
<PAGE>

         (d) Method of Payment. The purchase price for any share purchased
pursuant to the exercise of any Option granted under this Plan shall be paid in
full upon exercise of the Option by any of the following methods, to the extent
permitted under the particular Option Agreement: (i) by cash, (ii) by check or
(iii) by transferring to the Company shares of Common Stock at their Fair Market
Value as of the date of exercise of the Option. Notwithstanding the foregoing,
the Company may arrange for or cooperate in permitting cashless exercise
procedures and may extend and maintain, or arrange for the extension and
maintenance of, credit to a Participant to finance the Participant's purchase of
shares pursuant to the exercise of Options, on such terms as may be approved by
the Committee, subject to applicable regulations of the Federal Reserve Board
and any other applicable laws or regulations in effect at the time such credit
is extended.

         (e) Termination. No Option shall be exercisable more than ten years
after the date the Option is awarded. If a Participant owns or is deemed to own
(by reason of the attribution rules of Section 424(d) of the Code) more than 10%
of the total combined voting power of all classes of stock of the Company or any
Subsidiary or Parent of the Company and an Incentive Stock Option is awarded to
such Participant, such Option shall not be exercisable after the expiration of
five years from the date of award.

         (f) Exercise. No Option shall be exercisable during the lifetime of a
Participant by any person other than the Participant or his or her guardian or
legal representative. The Committee shall have the power to set the time or
times within which each Option shall be exercisable and to accelerate the time
or times of exercise of each Option, other than, in each case, Options awarded
or to be awarded to Non-Employee Directors. To the extent that a Participant has
the right to exercise one or more Options and purchase shares pursuant thereto,
the Options may be exercised from time to time by written notice to the Company
stating the number of shares being purchased and accompanied by payment in full
of the option price for such shares. Any certificate for shares of outstanding
Common Stock used to pay the option price shall be accompanied by a stock power
duly endorsed in blank by the registered owner of the certificate (with the
signature thereon guaranteed). In the event the certificate tendered by the
Participant in such payment covers more shares than are required for such
payment, the certificate shall also be accompanied by instructions from the
Participant to the Company's transfer agent with respect to the disposition of
the balance of the shares covered thereby.

         (g) Disability, Death, Retirement or Other Termination. The Committee
shall determine the effect on an Option (other than an Option awarded or to be
awarded to a Non-Employee Director) of the disability, death, retirement or
other termination of employment of a Participant and the extent to which, and
the period during which, the Participant's legal representative, guardian or
designated beneficiary may exercise rights thereunder.

         (h) Nontransferability. No Option or interest therein or right
thereunder shall be transferable by a Participant other than by will or the laws
of descent and distribution.

                                       5
<PAGE>

         (i) Limitations on Amount.

                  (1) If required by applicable tax rules regarding a particular
         grant, to the extent that the aggregate Fair Market Value (determined
         as of the date an Incentive Stock Option is granted) of the shares with
         respect to which an Incentive Stock Option grant under this Plan (when
         aggregated, if appropriate, with shares subject to other Incentive
         Stock Option grants made before said grant under this Plan or any other
         plan maintained by the Company or any Parent or Subsidiary of the
         Company) is exercisable for the first time by a Participant during any
         calendar year exceeds $100,000 (or such other limit as is prescribed by
         the Code), such Option grant shall be treated as a grant of
         Non-Qualified Stock Options pursuant to Code Section 422(d).

                  (2) In no event shall Options be granted to any one
         Participant to purchase more than 500,000 shares.

         (j) Disposition of Incentive Stock Options. A Participant shall notify
the Committee in the event that he or she disposes of Common Stock acquired upon
exercise of an Incentive Stock Option within the two-year period following the
date the Incentive Stock Option was granted or within the one-year period
following the date he or she received Common Stock upon the exercise of an
Incentive Stock Option.

         (k) Option Modification. The Committee may amend, modify or terminate
any outstanding Option held by a Participant other than a Non-Employee Director,
including substituting therefor another Option of the same or a different type,
changing the date of exercise or vesting and converting an Incentive Stock
Option to a Non-Qualified Stock Option, provided that the Participant's consent
to such action shall be required unless the Committee determines in its sole
discretion that the action, taking into account any related action, would not
materially and adversely affect the Participant.

                                   SECTION 7
                TERMS AND CONDITIONS OF RESTRICTED STOCK GRANTS

         (a) Restricted Stock Grants. Subject to the provisions of this Plan,
the Committee may award Restricted Stock Grants and determine the number of
shares of Restricted Stock covered by such Grant, the restrictions thereon
(which may include, without limitation, restrictions on the transfer of such
shares, restrictions on the right to vote such shares and restrictions on the
right to receive dividends on such shares), the time or times at which and the
conditions upon which such restrictions shall lapse, and the other terms and
conditions applicable to such Grant. Each Restricted Stock Grant may be made
alone or in combination with, in addition to or in relation to any other award
authorized by this Plan. The terms of each Restricted Stock Grant need not be
identical, and the Committee need not treat Participants uniformly. Except as
otherwise provided by this Plan or a particular Restricted Stock Agreement, any
determination with respect to a Restricted Stock Grant may be made by the
Committee at the time of award or at any time thereafter. The Committee may, but
shall not be

                                      6
<PAGE>

required to, award Restricted Stock Grants based upon the attainment of one or
more "performance goals" within the meaning of Section 162(m) of the Code and
applicable interpretive authority thereunder. In no event shall Restricted Stock
Grants covering more than 100,000 shares be granted to any one Participant.

         (b) Agreement in Writing; Provisions. Each Restricted Stock Grant shall
be evidenced by a written agreement (each, a "Restricted Stock Agreement")
delivered to the Participant specifying the terms and conditions thereof and
containing such other terms and conditions not inconsistent with the provisions
of this Plan as the Committee considers necessary or advisable to achieve the
purposes of this Plan or comply with applicable tax and regulatory laws and
accounting principles.

         (c) Delivery of Shares. Each share of Restricted Stock, when issued,
shall be issued in the name of the Participant and the certificate evidencing
such share shall be deposited with the Company, together with a stock power duly
endorsed in blank, upon such issuance and continuing until all applicable
restrictions on such share shall have lapsed.

         (d) Disability, Death, Retirement or Other Termination. The Committee
shall determine the effect on a Restricted Stock Grant (other than a Restricted
Stock Grant awarded or to be awarded to a Non-Employee Director) of the
disability, death, retirement or other termination of employment of a
Participant.

         (e) Nontransferability. Prior to the lapse of all restrictions thereon,
no share of Restricted Stock or interest therein or right thereunder shall be
transferable by a Participant otherwise than by will or the laws of descent and
distribution.

         (f) Restricted Stock Grant Modification. The Committee may amend,
modify or terminate any outstanding Restricted Stock Grant held by a Participant
other than a Non-Employee Director, including substituting therefor another
Restricted Stock Grant of the same or a different type and changing the time or
times at which any restrictions shall lapse, provided that the Participant's
consent to such action shall be required unless the Committee determines in its
sole discretion that the action, taking into account any related action, would
not materially and adversely affect the Participant.

                                    SECTION 8
                             NONDISCRETIONARY AWARDS
                            TO NON-EMPLOYEE DIRECTORS

         Notwithstanding any other provision of this Plan, Non-Employee
Directors shall participate in this Plan only to the extent set forth in this
Section 8. The provisions of this Plan applicable to awards granted or to be
granted to Non-Employee Directors are intended to comply with the provisions of
Rule 16b-3 under the Exchange Act, or any successor provision, and such
provisions shall be construed, interpreted and administered to so comply. The
Committee shall have no authority to take any action, and shall not take any
action, if the authority to take such action, or the taking of such action,
would result in noncompliance with such provisions.

                                       7
<PAGE>

         (a) Date of Grant; Number of Shares. On the date upon which a
Non-Employee Director is first elected or appointed a member of the Board, he
shall receive a grant of a Non-Qualified Stock Option to purchase 2,500 shares
of Common Stock. Non-Employee Directors subsequently re-elected at any Annual
Meeting of stockholders shall receive as of the date of such Annual Meeting
(commencing with the 2002 Annual Meeting), the grant of a Non-Qualified Stock
Option to purchase 2,500 shares of Common Stock. Options granted to Non-Employee
Directors shall be immediately exercisable.

         (b) Term. The term of each Option granted to a Non-Employee Director
shall be ten years from its date of grant, unless sooner terminated or extended
in accordance with Section 8(d) below.

         (c) Option Price. The option price of the shares of Common Stock
subject to each Option granted to a Non-Employee Director shall be the Fair
Market Value of such shares on the date the Option is granted.

         (d) Exercise after Death or Other Termination. If a Non-Employee
Director ceases to be a director of the Company, such Non-Employee Director's
Options shall be exercisable by him only during the six months following the
date such person ceases to be a director, except that:

                  (i) if a Non-Employee Director dies while serving as a
         director, such Non-Employee Director's Options shall be exercisable by
         his or her executor or administrator or, if not so exercised, by the
         legatees or the distributees of his or her estate, only during the six
         months following his or her death; and

                  (ii) notwithstanding the foregoing, a Non-Employee Director's
         Options shall terminate immediately on the date that such person is
         removed as a director for cause. For purposes of this Section 8, a
         Non-Employee Director shall be considered to have been dismissed "for
         cause" in the event he or she is dismissed on account of any act of (x)
         fraud or intentional misrepresentation or (y) embezzlement,
         misappropriation, or conversion of assets or opportunities of the
         Company or any Subsidiary of the Company.

                                    SECTION 9
                       ACCELERATION OF EXERCISABILITY AND
                       VESTING UNDER CERTAIN CIRCUMSTANCES

         Notwithstanding any provision in this Plan to the contrary, with regard
to any Option or Restricted Stock Grant awarded to any HOLDER OF AN OPTION,
unless the particular Option or Restricted Stock Agreement provides otherwise,
the Option will become immediately exercisable and vested in full, and all
restrictions on any shares of Restricted Stock subject to a Restricted Stock
Grant shall immediately lapse, upon the occurrence, before the expiration or
termination of such Option or forfeiture of such shares, of any of the events
listed below:

                                       8
<PAGE>

         (a) a sale, transfer or other conveyance of all or substantially all of
         the assets of the Company on a consolidated basis;

         (b) the acquisition of beneficial ownership (as such term is defined in
         Rule 13d-3 promulgated under the Exchange Act) by any "person" (as such
         term is used in Sections 13(d) and 14(d) of the Exchange Act), other
         than (i) the Company, (ii) James M. Hoak, or (iii) any of the
         affiliates of any of the foregoing, directly or indirectly, of
         securities representing 51% or more of the total number of votes that
         may be cast for the election of directors of the Company; or

         (c) the commencement (within the meaning of Rule 14d-2 promulgated
         under the Exchange Act) of a "tender offer" for stock of the Company
         subject to Section 14(d)(2) of the Exchange Act; or

         (d) the failure at any annual or special meeting of the Company's
         stockholders following an "election contest" subject to Rule 14a-11
         promulgated under the Exchange Act, of any of the persons nominated by
         the Company in the proxy material mailed to stockholders by the
         management of the Company to win election to seats on the Board,
         excluding only those who die, retire voluntarily, are disabled or are
         otherwise disqualified in the interim between their nomination and the
         date of the meeting.

                                   SECTION 10
                                  MISCELLANEOUS

         (a) No Right of Employment. No person shall have any claim or right to
be awarded an Option or Restricted Stock Grant, and the award of an Option or
Restricted Stock Grant shall not be construed as giving a Participant the right
to continued employment. The Company expressly reserves the right at any time to
dismiss a Participant free from any liability or claim under this Plan, except
as expressly provided in the applicable Option or Restricted Stock Agreement.

         (b) Plan Not Exclusive. Nothing contained in this Plan shall prevent
the Company from adopting other or additional compensation arrangements for its
employees or directors.

         (c) No Rights as Stockholders. Subject to the provisions of the
applicable Option or Restricted Stock Agreement, no Participant shall have any
rights as a stockholder with respect to any shares of Common Stock to be
distributed under this Plan until he or she becomes the record holder thereof.

         (d) Investment Representation. The Committee may require, as a
condition of receiving shares of Common Stock (including shares of Restricted
Stock) issued pursuant to any Option or Restricted Stock Grant, that a
Participant furnish to the Company such written representations and information
as the Committee deems appropriate to permit the Company, in light of the
existence or nonexistence of an effective Registration Statement under the
Securities Act, to deliver such shares in compliance with the provisions of the
Securities Act.

                                       9
<PAGE>

         (e) Section 16 Participants. The Committee shall have no authority to
take any action, and shall not take any action, if the authority to take such
action, or the taking of such action, would disqualify this Plan from the
exemption provided by Rule 16b-3.

         (f) Effectiveness. This Plan amendment and restatement shall become
effective upon its approval by the Board, subject to approval by the
stockholders of the Company. Prior to such stockholder approval, awards may be
granted under this Plan amendment and restatement subject to such stockholder
approval.

         (g) Amendment; Termination. The Board may amend, suspend or terminate
this Plan or any portion thereof at any time, provided that (i) no amendment
shall be made without stockholder approval if such approval is necessary to
comply with any applicable tax or regulatory requirement, including any
requirements for exemptive relief under Section 16(b) of the Exchange Act or any
successor provision, and (ii) Section 8 hereof and, as it relates to awards
granted or to be granted to Non-Employee Directors, Section 9 hereof may not be
amended more than once every six months other than to comport with changes in
the Code or ERISA or the rules and regulations under either thereof. If any
amendment, suspension or termination of this Plan shall materially and adversely
affect the rights of the holder of any award then outstanding, such amendment,
suspension or termination shall not be deemed to alter such rights unless the
holder shall consent thereto.

         (h) Term. Options and Restricted Stock Grants may not be awarded under
this Plan after ten years from the Effective Date, but then outstanding Options
and Restricted Stock Grants may extend beyond such date. Unless sooner
terminated, this Plan shall terminate on the tenth anniversary of the Effective
Date, provided that such termination shall not terminate or affect any Option or
Restricted Stock Grant then outstanding.

                                       10<PAGE>
                                                                   EXHIBIT 10(t)

                                LICENSE AGREEMENT

AGREEMENT MADE AND ENTERED INTO ON THE  o   DAY OF   o  , 2001.

BETWEEN:                                POWER TECHNOLOGY INC., a corporation,
                                        having its head office at 1000 W.
                                        Bonanza Road, Las Vegas, NV 89106,
                                        herein represented by Lee Balak,
                                        President, duly authorized to do so as
                                        he so declares;

                                        (hereinafter referred to as "LICENSOR");

AND:                                    GARTNER TRANS d.o.o., a corporation
                                        legally constituted under the laws of
                                        Slovania, having a principal office at
                                        Denova 5, 1000 Ljubljana, Slovania,
                                        herein represented by Walter Fischer,
                                        owner/director and Tamara Gaber,
                                        director, duly authorized to do so as
                                        they so declare;

                                        (hereinafter referred to as "LICENSEE");

WHEREAS LICENSOR is the owner of "PATENTS" (as hereinafter defined);

WHEREAS LICENSOR wishes to grant unto LICENSEE and LICENSEE wishes to acquire
from LICENSOR a exclusive License to enable LICENSEE to manufacture, produce,
sell, distribute and promote the "PRODUCTS" (as hereinafter defined) throughout
the "TERRITORY" (as hereinafter defined), the whole in accordance with the terms
and conditions set forth in this Agreement.

NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:

1.       DEFINITIONS

In this Agreement:

1.1 "PATENTS" shall mean Electrochemical battery structure and method US Patent
6,060,198 as well as any extension, division, continuation, revalidation,
reissue or renewal of same including, without limiting the generality of the
foregoing, the patent applications and patents described in Schedule "B" hereto;

<PAGE>

                                       2

1.2 "CONTRACT YEAR" shall mean that period of time commencing upon the signature
of this Agreement and ending on August 21, 2008 and any subsequent calendar
year;

1.3 "PRODUCTS" shall mean the reticulated plates and any derived products
manufactured or produced by LICENSEE under this license including, without
limitation, batteries of all sorts;

1.4      "TERRITORY" shall mean the following countries of Eastern Europe:

SLOVANIA, CROATIA, SERBIA, YUGOSLAVIA, BULGARIA, RUMANIA, POLAND, SLOVAKIA,
RUSSIA.

2.       GRANT OF LICENSE

2.1 LICENSOR hereby grants unto LICENSEE, the latter hereby accepting, the
exclusive license to manufacture, produce, sell and distribute the PRODUCTS in
the TERRITORY and for no other purpose.

2.2      Void

2.3 LICENSEE further undertakes to have each of its managers and other key
employees sign a confidentiality and non-competition agreement to the same
effect as Section 5 in a form acceptable to LICENSOR.

3.       INFORMATION AND ASSISTANCE

3.1 LICENSOR will promptly, after the execution of this Agreement, complete the
information disclosure from LICENSOR to LICENSEE, including making available to
LICENSEE and its representatives any portion of the Confidential Information
required by LICENSEE to use the PATENTS which has not previously been
communicated to LICENSEE.

3.2 Subject to paragraph 3.3, LICENSOR shall, at LICENSEE's reasonable request,
provide technical assistance to LICENSEE and otherwise cooperate with and assist
LICENSEE in order to use the PATENTS and produce and manufacture the PRODUCTS.

3.3 Thereafter, LICENSOR shall make its technical staff available to LICENSEE
according to terms and conditions to be negotiated between the Parties. At all
times, any and all travelling, lodging, meals and related expenses incurred by
the LICENSOR's staff at the request of LICENSEE shall be borne by the LICENSEE.

3.4 All decisions relating to the filing, prosecution and maintenance of the
Patents shall rest exclusively with LICENSOR which shall assume all costs
related thereto.

<PAGE>

                                       3

4.       CONSIDERATION

4.1 As consideration for the entering into of this Agreement and for the rights
granted herein, LICENSEE undertakes and agrees to pay to LICENSOR the following:

         (a)      a license fee of TWO HUNDRED FIFTY THOUSAND US DOLLARS
                  (US$250,000.00) upon execution hereof; and

         (b)      a royalty of ONE DOLLAR FIFTY CENTS US (US$1.50) per PRODUCT
                  sold by LICENSEE ("ROYALTIES").

4.2 All Royalties shall be paid quarterly, within thirty and shall be
accompanied by a report indicating, with respect to each country, the number of
PRODUCTS sold by LICENSEE. The payment of all Royalties shall be made in U.S.
Currency by bank transfer to the bank that LICENSOR may indicate to LICENSEE
from time to time.

4.3 If the payment of the Royalties is delayed for any reason, interest shall
accrue on the unpaid principal amount of the Royalties from and after the date
on which the same became due pursuant to this Section 4 at a rate equal to
eighteen percent (18%) per annum calculated from the date upon which such amount
was due. Accrued interests will bear interest at the same rate.

4.4 In order that the Royalties payable hereunder may be accurately determined,
and the statements provided for herein above be verified, LICENSEE undertakes
and agrees to keep full, clear, accurate and complete books and records relating
to its operations under this Agreement, to be kept available for at least five
(5) years. All of the said records and books of LICENSEE shall be open at all
reasonable times and upon reasonable notice during business hours throughout the
term of this Agreement and for a period of five (5) years thereafter for
inspection and audit by any duly authorized representative or representatives of
LICENSOR, at the latter's expense, to ascertain the accuracy of the Royalties
payments made hereunder by LICENSEE, provided however, that if there shall have
been an error in favour of the LICENSEE in excess of two percent (2%) in
computing Royalties for the period audited, all reasonable expenses in
connection with such inspection and audit shall be borne by and paid for by
LICENSEE.

4.5 LICENSEE shall allocate all Royalties payable hereunder separately for each
country and all required statements to be provided to LICENSOR hereunder by
LICENSEE shall be separate and distinct with respect to each country. All
monetary amounts stated therein shall refer to the lawful currency of the United
States of America.

4.6 Upon the demand of LICENSOR, but not more than once during any calendar
year, LICENSEE shall at its expense furnish to LICENSOR a detailed statement by
an independent Chartered Accountant, Certified Public Accountant or equivalent
professional accountant in LICENSEE's country attesting to the Royalties due and
payable hereunder as of LICENSEE's last fiscal year end.

<PAGE>

                                       4

4.7 Receipt or acceptance by LICENSOR of any statement furnished pursuant to
this Agreement or any sum paid hereunder shall not preclude LICENSOR from
questioning the correctness thereof at any time during the period of five (5)
years from receipt thereof but not thereafter, and in the event that any mistake
is discovered in any such statement or payment, and LICENSEE is appraised
thereof, LICENSEE shall immediately rectify same.

4.8 For the purpose of this Section 4, LICENSEE agrees that LICENSOR shall have
the right to inspect at all reasonable times any and all locations where
LICENSEE designs, produces, manufactures, distributes or sells any PRODUCTS.

5.       CONFIDENTIAL INFORMATION

5.1 Each Party agrees to maintain the confidentiality of the Confidential
Information of the other Party and not to disclose, directly or indirectly, any
part to anyone without prior written authorization from the other Party.

5.2 Each Party agrees not to use, directly or indirectly, any Confidential
Information of the other Party for purposes other than as provided herein and
not to assist or collaborate with third parties using, directly or indirectly,
any similar Confidential Information for purposes other than those provided for
in the present Agreement, without prior written authorization from the other
Party.

5.3 The confidentiality and non-use undertakings specified in the present
Agreement do not apply to any part of the Confidential Information which,
through no breach of the provisions of the present Agreement:

5.3.1    the recipient can demonstrate was in the public domain at the time of
         disclosure of such information by the LICENSOR;

5.3.2    the recipient can demonstrate was in its possession, prior to
         disclosure of such information by the LICENSOR and had not been
         previously obtained directly or indirectly from the LICENSOR;

5.3.3    the recipient can demonstrate it had received from a third party after
         disclosure of such information by the LICENSOR hereunder, as a matter
         of right and having no direct or indirect obligation to the LICENSOR
         with respect to same, provided that such third party did not acquire
         such information directly or indirectly from the LICENSOR; or

5.3.4    must be disclosed by virtue of the law but only to the extent
         specifically required.

5.4 Notwithstanding the above, Confidential Information will not be deemed to be
in the public domain or to have been known by a party mainly because it is
embraced by more general information previously known to it or merely because it
is expressed in publications, books, patents or other literature in general
terms not specifically including such Confidential Information disclosed or made
available to the other Party.

<PAGE>

                                       5

5.5 Each Party undertakes to cause those of its directors, officers,
shareholders, senior management personnel or other employees who are likely, by
reason of their functions, to have access to any part of the Confidential
Information from the other Party, to sign an agreement in which said director,
officer, shareholder, senior management personnel or employee agrees to treat
Confidential Information learned during the course of his employment in the same
manner as LICENSOR or LICENSEE treats such information.

5.6 Each Party acknowledges that any violation of the provisions of this Section
5 would result in irreparable injury to the other Party for which no adequate
remedy at law may be available, and such party accordingly consents to the
issuance of an injunction prohibiting any conduct by such Party in violation of
the provisions of this Section 5, without prejudice to any other rights which
the other party may have in the circumstances, including the right to claim
damages.

5.7 Any Party who violates one of the provisions of the present section 5 shall
pay to the Party who is the owner of the Confidential Information that is the
object of a violation, all the advantages or other profits that such party may,
directly or indirectly, gain as well as to compensate it for any damages that
the Party may suffer following such violation, including, without limitation,
loss of profits.

5.8 The confidentiality and non-use undertakings herein mentioned will remain in
full force and effect during the whole term of the present Agreement and shall
survive termination or expiration hereof.

6.       DEVELOPMENTS AND IMPROVEMENTS

6.1 LICENSEE hereby agrees to notify the LICENSOR promptly of any improvement to
the PATENTS within the scope of this Agreement, which it may develop or which
may be brought to its attention. It is understood that any improvement
("IMPROVEMENT") to the PATENTS developed by LICENSEE or its allowed
sub-contractors or sub-licensee during the term of this Agreement shall be owned
exclusively by LICENSOR and details thereof and same shall automatically be
included under the terms of the License granted by this Agreement. To the extent
that any part of the IMPROVEMENTS is not construed to be the exclusive property
of LICENSOR, LICENSEE, on its behalf, on behalf of its employees and any others
used by LICENSEE, hereby irrevocably assigns to LICENSOR all rights, title and
interests to all such part of the IMPROVEMENTS and hereby irrevocably waives all
moral rights in all such part of the IMPROVEMENTS and hereby agrees to obtain
specific assignments from its employees and any others used by it to give full
force and effect to the foregoing. LICENSEE hereby agrees to do all things
necessary to enable LICENSOR to secure patents, copyrights and other rights
relating to the IMPROVEMENTS, including, without limitation, the execution of a
specific assignment of title to any part of the IMPROVEMENTS to LICENSOR.

<PAGE>

                                       6

7.       MARKETING AND SALES PROMOTIONS

7.1 LICENSEE shall use its best efforts to manufacture, produce, promote, sell
and distribute the PRODUCTS in the TERRITORY, the whole in accordance with the
terms and conditions set forth in this Agreement.

8.       MINIMUM SALES

8.1 In the event that the cumulative total number of PRODUCTS sold by LICENSEE
at the end of Contract Years 2002, 2003 and 2004 are less than, respectively 0 ,
600,000 and 600,000 , LICENSOR will have the right, at its option, to terminate
the Agreement. Paragraphs 13.3 to 13.5 hereof will apply to such termination. In
the event that this Agreement is renewed after its initial term of three (3)
years in accordance with Section 12 hereof, the parties shall mutually agree in
writing, prior to the renewal of this Agreement, on the minimum sales
requirements for each further term of this Agreement.

9.       INFRINGEMENT OF INTELLECTUAL PROPERTY

9.1 LICENSEE and LICENSOR agree to notify each other, in writing, of any acts of
infringement relating to the PATENTS immediately after any such acts are brought
to its attention or it has otherwise acquired knowledge thereof. The Parties
agree to consult with each other as to how to respond to each infringement. If
the Parties jointly conclude that legal action should be taken with respect to
such infringement, LICENSOR and LICENSEE shall promptly and diligently prosecute
such action and shall each pay one-half ( 1/2) of all costs and expenses and
receive one-half ( 1/2) of all recoveries and awards with respect to said
action. If LICENSEE advises LICENSOR that it does not intend to participate in
any legal action, then LICENSOR shall be free to prosecute said action on its
behalf and it shall pay all costs and expenses and receive all recoveries and
awards therefrom. In the event LICENSOR advises LICENSEE that it will not
participate in such legal action, then LICENSEE shall be free to prosecute such
action as LICENSEE may deem advisable and in that connection, LICENSOR shall
assist LICENSEE in all reasonable ways and at all reasonable times, and LICENSEE
shall have the right to use the name of LICENSOR as a party to the proceedings,
either solely or jointly with LICENSEE's own name, provided that LICENSEE shall
pay all costs and expenses and receive all recoveries and awards in connection
with such proceedings and further provided, however, that LICENSOR shall always
be free, at his own cost and expense, to subsequently join in any pending
action. In any event, the parties hereby agree to cooperate fully with each
other in the prosecution of any such action.

9.2 In the event that any suit, action, or other proceeding shall be brought
against LICENSEE involving any claim of Patent infringement based upon
LICENSEE's manufacture, production, use and/or sale of any PRODUCTS, and as
often as the same shall occur, LICENSEE shall promptly send to LICENSOR a copy
of all proceedings which have been served in such suit, action or other
proceeding. In the defence of any

<PAGE>

                                       7

such claim, LICENSOR will cooperate fully with LICENSEE, and will, from time to
time, make available to LICENSEE all relevant records, papers, information,
samples, specimens and other similar material. However, LICENSOR shall bear no
obligation to hold harmless LICENSEE from and against any and all liabilities,
damages, costs and expenses of any nature whatsoever (including but no limited
to attorney's fees) incurred by LICENSEE in connection therewith.

9.3 LICENSEE agrees and undertakes not to contest, directly or indirectly, the
ownership or validity of the Patents and acknowledges that same are the
exclusive property of LICENSOR.

10.      MAINTENANCE OF STANDARDS

10.1 PRODUCTS manufactured and produced by LICENSEE shall be in strict
accordance with all applicable governmental standards, laws, rules and
regulations and with standards of quality, workmanship and performance
reasonably stipulated from time to time by LICENSOR. LICENSEE shall permit
authorized representatives of LICENSOR to inspect during normal business hours
the PRODUCTS manufactured and produced by LICENSEE in order to ensure that such
PRODUCTS meet LICENSOR's standards of quality, workmanship and performance.
LICENSEE shall cause truthful and accurate labeling regarding the care,
maintenance and use of the PRODUCTS, where applicable, to be affixed to such
PRODUCTS.

10.2 LICENSEE shall indemnify and save and hold harmless LICENSOR from any
liabilities, claims, causes of action, suits, damages and expenses (including
reasonable attorney's fees and expenses) which LICENSOR is or becomes liable
for, or may incur, or be compelled or pay by reason of any acts, whether of
omission or commission that may be committed or suffered by LICENSEE or any of
its servants, agents or employees in connection with LICENSEE's performance
under the terms of this Agreement or arising out of the use of the Products
manufactured or produced by or on behalf of or sold by LICENSEE. LICENSEE, in
addition, shall assume all warranty obligations to its customers in respect of
such PRODUCTS, and LICENSOR shall have no liability either to LICENSEE or to its
customers in respect of such warranty obligations. The obligations of LICENSEE
under this section 10.2 shall survive expiration of termination of this
Agreement.

11.      SUB-LICENSE AND ASSIGNMENT

11.1 LICENSEE shall not sub-license and/or assign the rights and license granted
pursuant to the terms of this Agreement without prior written consent of
LICENSOR.

12.      TERM OF AGREEMENT

12.1 This Agreement shall commence upon the execution of these presents and
shall expire on the 21 day of August , 2008, unless previously terminated in
accordance with the terms of this Agreement.

<PAGE>

                                       8

12.2 This Agreement shall be deemed to be automatically renewed for two (2)
further terms ("ADDITIONAL TERMS") of two (2) years each, provided that LICENSEE
has met the minimum sale requirements at the end of each Contract Year or at the
end of each ADDITIONAL TERM of this Agreement, as applicable, the whole as
provided for in Section 8.1 hereof.

13.      TERMINATION

13.1 The occurrence of any one or more of the following events (hereinafter
referred to as the "EVENTS OF DEFAULT") shall constitute a default under this
Agreement:

13.1.1   if any payment by LICENSEE to LICENSOR is not made on its due day;

13.1.2   if LICENSEE institutes proceedings seeking relief under a bankruptcy
         law or any similar law, or consents to entry of an order for relief
         against it in any bankruptcy or insolvency proceeding or similar
         proceeding, or files a petition for or consent or answer consenting to
         reorganization or other relief under any bankruptcy act or other
         similar law, or consents to the filing against it of any petition for
         the appointment of a receiver, liquidator, assignee, trustee,
         sequestration (or other similar official) of it or of any substantial
         part of its property, or makes an assignment for the benefit of
         creditors, or admits in writing its inability to pay its debts as they
         become due, or takes any action in furtherance of the foregoing;

13.1.3   the calling of a meeting of creditors, appointment of a committee of
         creditors or liquidating agents, or offering of a composition or
         extension to creditors by, for or of LICENSEE;

13.1.4   if LICENSEE breaches any other material provision of this Agreement.

13.2 In the event of a default specified in sub-paragraph 13.1.4 which is not
corrected within ten (10) days of notice of such default, LICENSOR thereafter
shall have the right to immediately terminate this Agreement. In the event of a
default specified in sub-paragraphs 13.1.1, 13.1.2 and 13.1.3, LICENSOR will
have the right to immediately terminate this Agreement without notice.

13.3 No assignee for the benefit of creditors, receiver, liquidator,
sequestration, trustee in bankruptcy, sheriff or any other officer of the court
or official charged with taking over custody of LICENSEE's assets or business
shall have any right to continue the performance of this Agreement.

13.4 Expiration or termination of this Agreement shall not release LICENSEE from
any payments or obligations due and payable or accrued to LICENSOR or rescind
any payment made or paid prior to the time such expiration or termination
becomes effective nor release LICENSEE from those obligations hereunder which
survive expiration or termination. Furthermore, termination of this Agreement
prior to the expiration of its term shall be without prejudice to any other
rights which LICENSOR may have against

<PAGE>

                                       9

LICENSEE, including, without limitation, damages for breach to the extent that
same may be recoverable.

13.5 Upon the expiration or termination of this Agreement, LICENSEE shall
forthwith cease the use of any Patents.

14.      REPRESENTATIONS AND WARRANTIES OF THE PARTIES

14.1     LICENSOR hereby represents and warrants unto LICENSEE that:

14.1.1   it owns the Patents and that it has every legal right to enter into
         this Agreement and to perform the terms and conditions hereof or its
         part to be performed, free of any encumbrances whatsoever;

14.1.2   it owns the PATENTS and there is no outstanding license granted by it
         which would in any way conflict with the license granted hereby to
         LICENSEE or which will in any manner prevent LICENSEE from developing,
         manufacturing, producing, distributing or selling the PRODUCTS;

14.1.3   LICENSOR has not received any notice that the manufacture, sale or use
         of the PRODUCTS by LICENSEE will constitute an infringement of any
         patents or other proprietary rights owned by any third party;

14.1.4   LICENSOR has made no investigations as to the matters set forth in
         sub-paragraph 14.1.3. LICENSEE agrees that LICENSOR will not be charged
         with constructive knowledge of any such infringement or conflict.

14.2 LICENSOR disclaims all liability for any direct or indirect damage of any
nature caused by or resulting from a defect in the manufacture, design,
production or use of the PRODUCTS.

14.3 LICENSEE hereby represents and warrants unto LICENSOR that it has every
legal right and authorization to enter into this Agreement and to perform the
terms and conditions hereof or its part to be performed, free of any
encumbrances whatsoever.

15.      DISCLAIMER OF PARTNERSHIP AND AGENCY

15.1 This is an Agreement between separate entities and neither is the agent or
servant of the other for any purpose whatsoever. LICENSEE is an independent
contractor and does not have any power nor will it represent itself as having
any power to in any way bind or obligate LICENSOR or to assume or create any
expressed or implied obligation or responsibility on behalf of LICENSOR or in
LICENSOR's name. This Agreement shall not be construed as constituting LICENSEE
and LICENSOR as partners or to create any other form of legal association which
would impose liability upon one party for the act or failure to act of the
other.

<PAGE>

                                       10

16.      WAIVER OF DEFAULT

16.1 The failure of any party at any time to take action against the other
party, or the failure of either party to terminate the present Agreement as
provided herein, shall not affect either party's right to require full
performance of this Agreement at any time thereafter, and the waiver by either
party of a breach of any provision of this Agreement shall not constitute a
waiver of any subsequent breach thereof nor nullify the effectiveness of such
provisions or the right of such party to demand redress for their respective
losses, damages and prejudices.

17.      SCOPE OF AGREEMENT

17.1 This Agreement which constitutes the entire agreement between the parties
pertaining to the subject matter thereof and no representations, inducements,
promises or agreements, or otherwise, between the Parties not embodied therein
shall remain in force and effect. No change, termination or waiver of any of its
provisions hereunder shall be binding upon the parties unless in writing and
signed by them.

18.      SUCCESSORS

18.1 Subject to the provisions of Section 11 and 13 hereof, the rights and
liabilities of the Parties shall bind and enure to the benefit of their
respective successors and assigns.

19.      SEVERABILITY

19.1 The invalidity of any particular provision of this Agreement shall not
affect any other provision hereof, and the Agreement shall be construed as if
any such invalidated provisions were omitted.

20.      NOTICES

20.1 Any notice, demand, consent or other communication required or permitted to
be given under this Agreement (collectively and individually the "Notice") shall
be in writing and addressed to their addressee at their address stated hereunder
or such addresses as the parties may specify from time to time by written
notice. The relevant addresses of the parties hereto are as follows:

20.1.1   If to LICENSOR:             To the attention of the President at the
                                     address indicated above.

20.1.2   With a copy to:             Me Charles Chevrette

                                     Mendelsohn Rosentzveig Shacter
                                     1000 Sherbrooke Street West
                                     27th Floor
                                     Montreal QC
                                     H3A 3G4

<PAGE>

                                       11

20.1.3   If to LICENSEE:             To the attention of the President at the
                                     address indicated above.

20.2 Notices may be delivered by hand, registered mail or fax and shall be
deemed to have been received as follows:

20.2.1   If delivered by hand:       at the time of delivery to a person who
                                     appears reasonably to be in charge.

20.2.2   If sent by fax:             at the time of confirmed transmission
                                     provided a confirmation copy is sent by
                                     airmail or registered mail within 24 hours
                                     after the transmission.

20.2.3   If sent by registered mail: at the time of delivery or of attempted
                                     delivery in the case delivery cannot be
                                     completed due to no fault of the sender.

20.3 If the time of such deemed receipt as provided in paragraph 20.2 hereof is
not during the customary hours of business, the Notice shall be deemed to have
been received at 10:00 a.m. at the place of delivery on the first customary day
of business thereafter.

20.4     All Notices shall be in the English language.

21.      FURTHER AGREEMENT

21.1 The parties agree to execute such further or other documents and assurances
which may be required from time to time in order to give effect to the
provisions of this Agreement.

22.      APPLICABLE LAW

22.1 This Agreement shall be governed by the laws applicable in the
United-Kingdom.

22.2 All disputes arising out of or relating to the formation, terms, breach or
alleged breach of this Agreement shall be finally settled under the Rules of
Arbitration of the International Chamber of Commerce by one or more arbitrators
appointed in accordance with such rules. Each party hereby irrevocably consents
to the jurisdiction of the ICC Court of Arbitration, and waives any objection to
such jurisdiction it may have based on forum non conviens or similar objection.
The place of arbitration shall be England. The arbitration shall be conducted in
English and all documents and agreements relative to any such dispute shall be
read, interpreted, and construed from

<PAGE>

                                       12

the English versions thereof. The award rendered shall be final and binding upon
both parties. Judgment upon the award may be entered in any court having
jurisdiction, or application may be made to such court for judicial acceptance
of the award and/or an order of enforcement as the case may be. Notwithstanding
the foregoing, either party may seek equitable or similar relief from any court
having jurisdiction thereof. In the event that any action or arbitration
proceeding is brought for any breach or default of any of the terms of this
Agreement, or otherwise in connection with this Agreement, the prevailing party
shall be entitled to recover from the other party all costs and expenses
incurred in that action or proceeding, or any appeal therefrom, including
without limitation, all attorneys' fees and costs actually incurred.

23.      GENERAL PROVISIONS

23.1 The preamble and the Schedules herein shall be deemed to form part of this
Agreement.

23.2 The division of the terms of this Agreement into separate articles and the
headings in the Agreement are for convenience and reference only and shall have
no bearing on the instruction or interpretation of its terms.

23.3 LICENSOR and LICENSEE hereby waive to the fullest extent permitted by law
(and to the extent that such waiver is not contrary to any statutory provisions
in force in the TERRITORY), any right to or claim for any punitive or exemplary
damages against the other and agree that in the event of a dispute between them,
each shall be limited to the recovery of any actual damages sustained by it.

23.4 This Agreement has been drafted in the English language at the request of
the parties.

IN WITNESS WHEREOF, the parties have signed on the date first above mentioned.

                                       POWER TECHNOLOGY INC.

                                       Per:
                                           -------------------------------------
                                           Lee Balak

                                       GARTNER TRANS d.o.o.

                                       Per:
                                           -------------------------------------
                                           Walter Fischer

                                       Per:
                                           -------------------------------------
                                           Tamara Gaber

<PAGE>

                                       13

                                  SCHEDULE "A"

                          PATENTS & PATENT APPLICATIONS

                COUNTRY              PATENT/                    DATE
                               PATENT APPLICATIONS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00032-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00032-of-00352.parquet"}]]